Malonyl coenzyme A and adiposity in the Dahl salt-sensitive rat: Effects of pioglitazone

Metabolism: Clinical and Experimental

Volumn 45, Issue 4, 1996, Pages 519-525

  Kurowski, T G ^b   Saha, A K ^b   Cunningham, B A ^b   Holbert, R I ^b   Colca, J R ^b   Corkey, B E ^b   Ruderman, N B ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MALONYL COENZYME A; PIOGLITAZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOHYDRATE DIET; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; GLUCOSE INTOLERANCE; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPID DIET; NONHUMAN; PRIORITY JOURNAL; RAT; SALT INTAKE;

EID: 0029965471     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90230-9     Document Type: Article

References (40)

1. Brown DR, Morgan DA, Feuler JD, et al: 24-Hour blood pressure recordings in Dahl rats on high- and low-salt diets. Am J Physiol 257:R1225-R1231, 1989
2. Rapp JP, Dene H: Development and characteristics of inbred strains of Dahl salt-sensitive and salt-resistant rats. Hypertension 7:340-349, 1985
3. Reaven GM, Twersky J, Chang H: Abnormalities of carbohydrate and lipid metabolism in Dahl rats. Hypertension 18:630-635, 1991
4. Ferrannini E, Haffner SM, Mitchell BD, et al: Hyperinsulinemia: The key feature of a cardiovascular and metabolic syndrome. Diabetologia 34:416-422, 1991
5. Fuh MM-T, Shieh S-M, Wu D-A, et al: Abnormalities of carbohydrate and lipid metabolism in patients with hypertension. Arch Intern Med 147:1035-1038, 1987
6. Reaven GM: Insulin resistance and compensatory hyperinsulinemia: Role in hypertension, dyslipidemia, and coronary heart disease. Am Heart J 121:1283-1288, 1991
7. Reaven GM: Banting Lecture 1988. Role of insulin resistance in human diabetes. Diabetes 37:1595-1607, 1988
8. Ruderman NB, Schneider SH, Berchtold P: The "metabolically-obese," normal-weight individual. Am J Clin Nutr 34:1617-1621, 1981
9. Vaag A, Henriksen JE, Beck-Nielsen H: Decreased insulin activation of glycogen synthase in skeletal muscles in young non-obese caucasian first degree relatives of patients with noninsulin dependent diabetes mellitus. J Clin Invest 89:782-788, 1992
10. Colca JR, Morton DR: Antihyperglycemic thiazolidinediones: Ciglitazone and its analogs, in Bailey C, Flatt P (ed): New Anti-Diabetic Drugs. London, UK, Smith-Gordon, 1990, pp 255-261
11. y mouse: Effects of pioglitazone on malonyl CoA and diacylglycerol. Am J Physiol 267:E95-E101, 1994
12. ++-antagonist lanthanum. J Clin Invest 65:967-981, 1980
13. Bergmeyer HU, Bernt E, Schmidt F, et al: D-Glucose: Determination with hexokinase and glucose-6-phosphate dehydrogenase, in Bergmeyer HU (ed): Methods of Enzymatic Analysis, vol 3. New York, NY, Academic, 1974, pp 1196-1201
14. Denton RM, Randle PJ: Concentrations of glycerides and phospholipids in rat heart and gastrocnemius muscles: Effects of alloxan diabetes and perfusion. Biochem J 104:416-422, 1967
15. Preiss J, Loomis CR, Bishop WR, et al: Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes and ras- and sis-transformed normal rat kidney cells. J Biol Chem 261:8597-8600, 1986
16. McGarry JD, Stark MJ, Foster DW: Hepatic malonyl CoA levels of fed, fasted and diabetic rats as measured using a simple radioisotopic assay. J Biol Chem 253:8291-8293, 1978
17. Nagy K, Levy J, Grunberger G: High-fat feeding induces tissue-specific alteration in proportion of activated insulin receptors in rats. Acta Endocrinol (Copenh) 122:361-368, 1990
18. McGarry JD, Mills SE, Long CS, et al: Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat. Biochem J 214:21-28, 1983
19. Chen M-T, Kaufman LN, Spennetta T, et al: Effects of high-fat feeding to rats on the interrelationship of body weight, plasma insulin, and fatty acyl-coenzyme A esters in liver and skeletal muscle. Metabolism 41:564-569, 1992
20. Bianchi A, Evans JL, Nordlund A-C, et al: Acetyl-CoA carboxylase in Reuber hepatoma cells: Variation in enzyme activity, insulin regulation, and cellular lipid content. J Cell Biochem 48:86-97, 1992
21. Thampy KG: Formation of malonyl coenzyme A in rat heart. J Biol Chem 264:17631-17634, 1989
22. Kobayashi M, Iwanishi M, Egawa K, et al: Pioglitazone increases insulin sensitivity by activating insulin receptor kinase. Diabetes 41:476-483, 1992
23. Heydrick SJ, Ruderman NB, Kurowski TG, et al: Enhanced stimulation of diacylglycerol and lipid synthesis by insulin in denervated muscle: Altered protein kinase C activity and a possible link to insulin resistance. Diabetes 40:1707-1711, 1991
24. Turinsky J, O'Sullivan DM, Bayly BP: 1,2-Diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo. J Biol Chem 265:16880-16885, 1990
25. Surwit RS, Feinglos MN, Rodin J, et al: Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 44:645-651, 1995
26. Buchanan TA, Fisler JA, Underberger S, et al: Whole body insulin sensitivity in Osborne-Mendel and S 5B/P1 rats eating a low- or high-fat diet. Am J Physiol 263:R785-R789, 1992
27. Schemmel R, Mickelsen O, Gill JL: Dietary obesity in rats: Body weight and fat accretion in seven strains of rats. J Nutr 100:1041-1048, 1970
28. Bray GA: Obesity: A disorder of nutrient partitioning. The MONA LISA hypothesis. J Nutr 121:1146-1162, 1991
29. Flatt JP: Dietary fat, carbohydrate balance and weight maintenance. Ann NY Acad Sci 683:122-140, 1993
30. Chang S, Graham B, Yakuba F, et al: Metabolic differences between obesity-prone and obesity-resistant rats. Am J Physiol 259:R1103-R1110, 1990
31. Froidevaux F, Schultz Y, Christin L, et al: Energy expenditure in obese women before and during weight loss, after feeding, and in the weight-relapse period. Am J Clin Nutr 57:35-42, 1993
32. Astrup A, Benjamin B, Christensen NJ, et al: Failure to increase lipid oxidation in response to increasing dietary fat content in formerly obese women. Am J Physiol 266:E592-E599, 1994
33. Saha AK, Kurowski TG, Ruderman NB: A malonyl CoA fuel sensing mechanism in muscle: Effects of insulin, glucose and denervation. Am J Physiol 269:E283-E289, 1995
34. Prentki M, Vischer S, Glennon MC, et al: Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling factors in nutrient-induced insulin secretion. J Biol Chem 267:5802-5810, 1992
35. Corkey BE, Glennon MC, Chen KS, et al: A role for malonyl CoA in glucose stimulated insulin secretion from clonal pancreatic β-cells. J Biol Chem 264:21608-21612, 1989
36. Sugden MC, Holness MJ: Interactive regulation of the pyruvate dehydrogenase complex and the carnitine palmitoyltransferase system. FASEB J 8:54-61, 1994
37. Hofmann C, Lorenz K, Braithwaite SS, et al: Altered gene expression for tumor necrosis factor-α and its receptor during drug and dietary modulation of insulin resistance. Endocrinology 134:264-270, 1994
38. Hotamisligil GS, Spiegelman BM: Tumor necrosis factor alpha: A key component of the obesity-diabetes link. Diabetes 43:1271-1278, 1994
39. Nolan JJ, Ludvik B, Beerdsen P, et al: Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 331:1188-1193, 1994
40. Lehmann JM, Moore LB, Smith-Oliver TA, et al: An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ(PPARγ). J Biol Chem 270:12953-12956, 1995